Identification of potential inhibitor against Ebola virus VP35: insight into virtual screening, pharmacoinformatics profiling, and molecular dynamic studies-Reference-Cited by-同舟云学术

Identification of potential inhibitor against Ebola virus VP35: insight into virtual screening, pharmacoinformatics profiling, and molecular dynamic studies

Published:2022-02-24 Issue:3 Volume:33 Page:815-831
ISSN:1040-0400
Container-title:Structural Chemistry
language:en
Short-container-title:Struct Chem

Author:

Bhowmik Ratul,Manaithiya Ajay^ORCID,Vyas Bharti,Nath Ranajit,Rehman Sara,Roy Shubham,Roy Ratna

Publisher

Springer Science and Business Media LLC

Subject

Physical and Theoretical Chemistry,Condensed Matter Physics

Link

https://link.springer.com/content/pdf/10.1007/s11224-022-01899-y.pdf

Reference30 articles.

1. Weyer J, Grobbelaar A, Blumberg L (2015) Ebola virus disease: history, epidemiology, and Outbreaks. Curr Infect Dis Rep 17(5):480

2. Brown CS, Lee MS, Leung DW, Wang T, Xu W, Luthra P et al (2014) In silico derived small molecules bind the filovirus VP35 protein and inhibit its polymerase cofactor activity. J Mol Biol 426(10):2045–2058

3. Mohamad Yusoff MA, Abdul Hamid AA, Mohammad Bunori N, Abd Halim KB (2018) Interaction of monomeric Ebola VP40 protein with a plasma membrane: a coarse-grained molecular dynamics (CGMD) Simulation Study. J Mol Graph Model 82:137–144. https://doi.org/10.1016/j.jmgm.2018.04.010

4. Ahmad N, Farman A, Badshah SL, Ur Rahman A, ur Rashid H, Khan K (2017) Molecular modeling, simulation and Docking Study of Ebola virus glycoprotein. J Mol Graph Model 72:266–71. https://doi.org/10.1016/j.jmgm.2016.12.010

5. Holmes EC, Dudas G, Rambaut A, Andersen KG (2016) The evolution of ebola virus: insights from the 2013–2016 epidemic. Nature 538(7624):193–200. https://doi.org/10.1038/nature19790

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery, lead identification and exploration of potential oxadiazole derivatives in targeting STAT3 as anti-cancer agents;In Silico Pharmacology;2024-09-14

2. Repurposing FDA approved drugs against monkeypox virus DNA dependent RNA polymerase: virtual screening, normal mode analysis and molecular dynamics simulation studies;VirusDisease;2024-06

3. A virtual insight into mushroom secondary metabolites: 3D-QSAR, docking, pharmacophore-based analysis and molecular modeling to analyze their anti-breast cancer potential;Journal of Biomolecular Structure and Dynamics;2024-02

4. A Comparative Study of Montelukast and Salbutamol in Bronchial Asthma;International Journal of Scientific Research in Science and Technology;2022-09-01